Indivior, leader in opioid treatment, trades near 52-week lows. Read more on INDV stock's financials, growth challenges, and ...

Palantir achieved $1.25B FCF in FY24 with 29% revenue growth. U.S. commercial revenue soared 54%, fueled by scalable AI. See ...

Bridgewater Associates' flagship fund rose 9.9% in the first quarter, a source familiar with the matter said, even as the ...